Overview

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

Status:
Active, not recruiting
Trial end date:
2021-10-29
Target enrollment:
Participant gender:
Summary
Immunization with the inactivated influenza vaccine with blood samples collected at 7 visits (baseline, day 7, 14, 28, 60, 90 and 180, fine needle aspiration (FNAs) from axillary lymph nodes at baseline, days, 4, 14, 28, 60 and 180. BMA at baseline, days 28 and 180.
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Vaccines